My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
RES-2022-168
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
RES-2022-168
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/13/2022 11:54:56 AM
Creation date
9/13/2022 11:53:49 AM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
107
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
FINAL AGREEMENT 3.25.22 <br />Public education relating to immunity and Good Samaritan laws <br />Educating first responders regarding the existence and operation of immunity and <br />Good Samaritan laws. <br />Syringe service programs and other evidence-informed programs to reduce harms <br />associated with intravenous drug use, including supplies, staffing, space, peer <br />support services, referrals to treatment, fentanyl checking, connections to care, <br />and the full range of harm reduction and treatment services provided by these <br />programs. <br />10.Expanding access to testing and treatment for infectious diseases such as HIV and <br />Hepatitis C resulting from intravenous opioid use. <br />11 Supporting mobile units that offer or provide referrals to harm reduction services, <br />treatment, recovery supports, health care, or other appropriate services to persons <br />that use opioids or persons with OUD andany co-occurring SUD/MH conditions. <br />12.Providing training in harm reduction strategies to health care providers, students, <br />peer recovery coaches, recovery outreach specialists, or other professionals that <br />provide care to persons who use opioids or persons with OUD and any co- <br />occurring SUD/MH conditions. <br />13. Supporting screening for fentanyl in routine clinical toxicology testing <br />PART THREE: OTHER STRATEGIES <br />I. F'IRST RESPONDERS <br />In addition to items in section C, D and H relating to first responders, support the <br />following: <br />Education of law enforcement or other first responders regarding appropriate <br />practices and precautions when dealing with fentanyl or other drugs. <br />2.Provision of wellness and support services for first responders and others who <br />experience secondary traurna associated with opioid-related eilrergency events <br />J. LEADERSHIP, PLANNING AND COORDINATION <br />Support efforts to provide leadership, planning, coordination, facilitations, training and <br />technical assistance to abate the opioid epidemic through activities, programs, or <br />strategies that may include, but are not limited to, the following: <br />Statewide, regional, local or community regional planning to identify root causes <br />of addiction and overdose, goals for reducing harms related to the opioid <br />epidemic, and areas and populations with the greatest needs for treatment <br />7 <br />8 <br />9 <br />1 <br />1 <br />E-13
The URL can be used to link to this page
Your browser does not support the video tag.